Cerebral is doubling down on mental health and focusing on treating patients with serious mental illness. In turn, some of the company’s more “exploratory” efforts, such as expanding into primary care, are now on hold. The digital mental health company’s newly minted CEO, David Mou, told Behavioral Health Business that under his direction the company […]
Four venture capital principals in the health tech space called out and condemned the VC-backed startup ethos of growing at all costs in digital mental health. The principals, who spoke on a panel during the 2022 Going Digital: Behavioral Health Tech conference, also said bad actors in digital health reveal the need for industry standards […]
The scrutiny around mental health startup Cerebral Inc. following the company’s meteoric rise and subsequent criticism has generated new challenges for the company. A House committee has launched a review of how the Drug Enforcement Administration (DEA) has enforced the Ryan Haight Act, which dictates how controlled substances are allowed to be prescribed via telehealth. […]
Virtual therapy provider Talkspace Inc. (Nasdaq: TALK) could see a little more daylight in the virtual mental health market as Cerebral pivots away from prescribing controlled substances. While Talkspace itself has never prescribed controlled substances — it refers patients to in-person psychiatric services as needed — Talkspace Chief Financial Officer Jennifer Fulk said Cerebral’s decision […]
Digital mental health company Cerebral announced a round of layoffs planned for July 1. The company told Bloomberg News, which first broke the story, that the layoffs are an effort to focus on quality and make the company more efficient. The number of employees that will be laid off has not been announced. This news […]
Cerebral Inc.’s founding CEO is no longer leading the company. The company announced Wednesday afternoon that “Kyle Robertson leaves his position as CEO, effective immediately” and that Dr. David Mou is now CEO. However, Cerebral has not clarified whether or not Robertson legally remains a part of the company as an employee or investor. A […]
Cerebral Inc., a fast-growing mental health and medication management startup based in San Francisco, will stop prescribing most controlled substances by this fall. Chief Medical Officer David Mou told the company’s prescriber team that Cerebral is pulling back on prescribing controlled substances “[in] order to prepare for the expiration of the waiver to the Ryan […]
Digital mental health company Cerebral is mixing up its leadership team. The shakeup comes as the startup responds to recent criticism over its prescribing practices. Specifically, Cerebral is promoting current CMO Dr. David Mou to president and hiring Virginia Commonwealth University’s former chief ethics and compliance officer, Jacqueline Kniska, to head its compliance team. Meanwhile, […]
Over the last two months, digital mental health unicorn Cerebral has faced a wave of negative media attention. At the crux of these stories are the company’s prescribing practices, particularly its approach to prescribing controlled ADHD substances. At the American Telemedicine Conference in Boston, Cerebral CMO Dr. David Mou sought to clear the air and […]
Matthew Truebe, formerly the vice president of product and engineering at Cerebral Inc., alleges that he was retaliated against after raising questions about how the company handles prescription medication. As reported by Bloomberg Law, Truebe alleges he was fired a year after being hired because he apparently refused to sign an amendment to his employment […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
